newsfilter
← Latest News
GlobeNewswire·

Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference

  • Mineralys Therapeutics (NASDAQ: MLYS) announced management will attend the Bank of America Securities 2026 Health Care Conference in Las Vegas from May 11-14, 2026.
  • The company's fireside chat is scheduled for Tuesday, May 12, 2026, at 9:20am PT.
  • A live webcast of the session will be available via the "News & Events" page in the Investor Relations section of the Mineralys Therapeutics website.
  • Mineralys Therapeutics is a biopharmaceutical firm based in Radnor, Pennsylvania, focused on developing medicines for hypertension, CKD, OSA, and other diseases driven by dysregulated aldosterone.
  • The company's initial product candidate is lorundrostat, an orally administered, highly selective aldosterone synthase inhibitor.
  • Mineralys was founded by Catalys Pacific.